Overview: Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics for the treatment of solid tumors, with a market cap of $220.78 million. Operations: The company generates ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback